{
  "chapter": "Obstetrics-Hypertension In Pregnancy",
  "questions": [
    {
      "q_no": 1,
      "question": "A 30 y/o woman presents for her first prenatal visit. She’s a Primi and is concerned about her pregnancy, as her mother experienced pregnancy-induced hypertension (PIH) during her pregnancies. She is currently healthy and denies any medical problems. She is a smoker, and her BMI is 31. Which of the following is NOT a risk factor for PIH?",
      "options": {
        "A": "Primi",
        "B": "BMI > 30",
        "C": "Smoking",
        "D": "Family history of preeclampsia"
      },
      "correct_answer": "C",
      "explanation": "of developing hypertension during pregnancy. Risk factors of Pregnancy-induced hypertension: Nulliparity. Multiple Gestation. Preexisting Conditions: Chronic hypertension. Family History. Race/Ethnicity: African American. Age >35 years. Reference: William’s Textbook of Obstetrics, 26th Edition, Page 691.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 2,
      "question": "A 32-year-old pregnant woman is receiving magnesium sulfate for the management of severe preeclampsia. After several hours of infusion, she exhibits diminished patellar reflexes and mild respiratory depression. Her serum magnesium level is found to be 12 mg/dL. What is the most appropriate antidote for magnesium sulfate toxicity in this patient?",
      "options": {
        "A": "Sodium bicarbonate",
        "B": "Calcium gluconate",
        "C": "Potassium chloride",
        "D": "Magnesium citrate"
      },
      "correct_answer": "B",
      "explanation": "Correct answer: B) Calcium gluconate Explanation: Calcium gluconate is the antidote for magnesium sulfate toxicity . Administer 1 gram IV over a few minutes to reverse mild to moderate respiratory depression and restore reflexes. Magnesium Sulfate Toxicity: Monitor magnesium sulfate toxicity by observing deep tendon reflexes, respiratory status, and urine output (primarily excreted by kidneys) Impaired kidney function can lead to toxicity. Loss of patellar reflexes at ~12 mg/dL is an early warning sign. Serum Magnesium Testing: Routine testing is not recommended. Test 4-6 hours after starting infusion to adjust rate (target: 4-7 mEq/L or 4.8-8.4 mg/dL). Elevated serum creatinine ( ≥ 1.0 mg/dL) to assess kidney function. Check for toxicity signs (diminished reflexes, breathing issues) to confirm diagnosis and guide treatment. Administer fluids cautiously to avoid overload and pulmonary edema. Adverse Effects of Magnesium Sulfate: Mechanism: Acts as a smooth muscle relaxant. Serum Magnesium Level Effect 5-9 mg/dL Therapeutic range 9 mg/dL Loss of patellar reflexes 12 mg/dL Respiratory depression occurs at ~12 mEq/L (14.4 mg/dL) due to muscle paralysis 30 mg/dL Cardiac arrest Management of Magnesium Toxicity: Immediate Actions: Administer 10 mL 10% calcium gluconate IV over 3 minutes to reverse mild to moderate respiratory depression. Discontinue magnesium sulfate. Further Steps: Administer furosemide to increase urinary excretion. Severe respiratory depression requires intubation and mechanical ventilation. The effects of IV calcium may be short-lived if steady-state toxicity is present. Sodium bicarbonate (Option A) is used primarily in cases of metabolic acidosis, not for magnesium toxicity. Potassium chloride (Option C) is used to correct hypokalemia, not to counteract magnesium toxicity. Magnesium citrate (Option D) is a form of magnesium used as a laxative, but it does not counteract magnesium toxicity. Reference: Williams Obstetrics, 26th Edition, Page 719, 720 https://pubmed.ncbi.nlm.nih.gov/32443079/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 3,
      "question": "A 32-year-old woman at 34 weeks gestation presents to the emergency department with symptoms of eclampsia. The medical team decides to administer magnesium sulfate (MgSO4) for seizure prophylaxis. Which of the following correctly describes the regimen for magnesium sulfate administration ?",
      "options": {
        "A": "Pritchard: 4 g IV, then 1-2 g/hour IV infusion.",
        "B": "Zuspan: 4 g IV, then 10 g IM (5 g each buttock).",
        "C": "Pritchard: 4 g IV, then 10 g IM, 5 g IM every 4 hours.",
        "D": "Zuspan: 4 g IV, then 5 g IM every 4 hours."
      },
      "correct_answer": "C",
      "explanation": "every 4 hours. Magnesium sulfate is the preferred medication for preventing seizures in pregnant women with severe preeclampsia or eclampsia. There are two regimens to administer MgSO4: Regimen Loading Dose Maintenance Dose Notes Pritchard (IV and IM) (Option A ruled out) Administer 4 g IV over 3-5 mins (20 mL of 20% MgSO4 solution) Follow with 10 g of 50% MgSO4 solution: 5 g (10 mL of 50% solution) in each buttock as deep IM injection with 1 mL of 2% lidocaine in the same syringe. 5g IM with 1 mL of 2% lidocaine in alternate buttocks every 4 hours; continue for 24 hours after birth or last convulsion If convulsions recur after 15 min, give 2 g IV over 5 min (20% solution). Zuspan (IV only) (Option B & D ruled out) Administer 4-6 g IV over 15- 20 mins (20 mL of 20% magnesium sulfate solution). If convulsions recur after 15 mins, give 2g IV (10 mL of 20% MgSO4 solution) over 5 mins. 1-2 g IV infusion per hour (5 mL of 20% solution); continue for 24 hours after childbirth or last convulsion Use an infusion pump if available. Ensure dilution to 20% solution. Before Administration: Ensure respiratory rate is at least 16 per minute (not depressed). Confirm patellar reflexes are present. Verify that urinary output is at least 30 ml per hour over 4 hours. Signs of toxicity: If signs of toxicity are present, delay the next dose Respiratory rate below 16 breaths per minute. Patellar reflexes are absent. Urinary output falls below 30 ml per hour over the preceding 4 hours. Reference: https://www.bioline.org.br/pdf?am09018 Page 78. Williams Obstetrics, 26th Edition, Page 719. DC Dutta’s Textbook of Obstetrics, 9th Edition, Page 221.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 4,
      "question": "A 22-year-old pregnant woman with severe preeclampsia is receiving magnesium sulfate for seizure prophylaxis. Her current serum magnesium level is 7.5 mg/dL. What does this indicate regarding her magnesium sulfate therapy?",
      "options": {
        "A": "The level is within the therapeutic range for magnesium sulfate.",
        "B": "The level is below the therapeutic range for magnesium sulfate.",
        "C": "The level indicates the potential toxicity of magnesium sulfate.",
        "D": "The level indicates a need for immediate cessation of magnesium sulfate."
      },
      "correct_answer": "A",
      "explanation": "mg/dL falls within this range, indicating appropriate therapeutic dosing. Aspect Details MOA NMDA Receptor Blockade Calcium Channel Blockade: Reduces calcium influx into neurons. Vasodilation: Improves cerebral blood flow and reduces cerebral edema, dilates uterine arteries, increases endothelial prostacyclin production and inhibits platelet activation. Uses Prevent seizures in severe preeclampsia and eclampsia. Prevent recurrent seizures in eclampsia. Tocolytic effect (delaying preterm labor). Neuroprotective: Protects the preterm baby's brain from damage by reducing the risk of cerebral palsy. Therapeutic Range To control fits, the optimum serum magnesium is 4.8–8.4 mg/dL (4–7 mEq/L). Deep tendon reflex loss at 9 mg/dL (>7 mEq/L). C/I Myasthenia gravis, hypocalcemia, moderate-to-severe renal failure, cardiac ischemia, heart block, myocarditis. Avoid if alternatives are justified. Administration and Dosage Administer: Intravenously or intramuscularly. Loading dose: 4–6 g IV over 20–30 minutes. (Zuspan or Sibai regimen) Maintenance: 1–2 g/hour IV. Monitor urine output and reflexes. Dosage Adjustment Adjust for renal dysfunction. Adverse Effects Primarily smooth muscle relaxant: Respiratory depression (at 12 mg/dL) and cardiac arrest (at 30 mg/dL). Manage with calcium gluconate 10% and furosemide if needed. Reference: https://pubmed.ncbi.nlm.nih.gov/36822712/ https://pubmed.ncbi.nlm.nih.gov/32443079/ William’s Obstetrics, 26th Edition, Page 719.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 5,
      "question": "A 28-year-old pregnant woman at 32 weeks of gestation presents to the clinic with blood pressure readings consistently around 160/104 mmHg. She has no proteinuria or other symptoms of end-organ damage. She is diagnosed with gestational hypertension. Which antihypertensive medication is considered the first-line treatment for managing this patient's condition?",
      "options": {
        "A": "Nifedipine",
        "B": "Methyldopa",
        "C": "Hydralazine",
        "D": "Labetalol"
      },
      "correct_answer": "D",
      "explanation": "Correct answer: D) Labetalol Explanation: Labetalol is the preferred antihypertensive for managing gestational hypertension due to its safety profile and effectiveness in lowering blood pressure in pregnant women. Antihypertensive Treatment During Pregnancy First-line drugs: Drug Class Examples Notes Beta-blockers Labetalol Preferred. Generally safe and effective Calcium channel blockers Nifedipine (Option A ruled out) , Amlodipine Safe, less BP variability compared to labetalol Labetalol commonly treats acute severe hypertension in pregnancy. Initial IV dose: 10–20 mg, then 20–80 mg every 10–30 mins up to 300 mg. Continuous IV infusion: 1–2 mg/min. Fewer side effects than alternatives; less tachycardia. Avoid in asthma, heart disease, compromised heart function, heart block, or bradycardia. Methyl dopa (Option B ruled out) an alpha agonist is less effective in severe hypertension and has sedative side effects. It acts centrally and by reducing sympathetic outflow to affect a generalized decreased vascular tone. Second-line drugs: Drug Class Examples Notes Vasodilators Hydralazine (Option C ruled out) Reserved for cases with cardiac/renal dysfunction Contraindicated drugs: Drug Class Examples Notes ACE inhibitors Enalapril, Lisinopril Associated with severe fetal malformations Angiotensin-receptor blockers Losartan, Valsartan Not recommended at any point during pregnancy Pre-existing Medication Management: ACE Inhibitors/ARBs: Discontinue immediately upon pregnancy recognition. Other Antihypertensives: Mild/Moderate Hypertension: Some guidelines suggest discontinuation in the first trimester and restart if BP approaches severe range. Reference: Williams Obstetrics, 26th Edition, Page 950, 951.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 6,
      "question": "A 32-year-old pregnant woman presents at 30 weeks of gestation with BP of 170/110 mmHg and proteinuria. She is stable without evidence of end-organ damage. According to the algorithm for managing severe preeclampsia, what is the recommended management approach?",
      "options": {
        "A": "Immediate delivery",
        "B": "Consider expectant management in a tertiary care centre",
        "C": "Monitor closely for 24 hours and discharge",
        "D": "Administer antenatal corticosteroids and terminate pregnancy"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Consider expectant management in a tertiary care centre. Explanation: Before 34 weeks of gestation with severe hypertension (BP > 160/110mm Hg), expectant management may prolong pregnancy to improve neonatal outcomes if maternal and fetal conditions are stable. Algorithm for Treating Preeclampsia Initial Evaluation Perform comprehensive maternal and fetal evaluation. CBC with platelet estimate, serum creatinine, LDH, AST, ALT, and proteinuria testing. Fetal evaluation: USG for estimated fetal weight, amniotic fluid volume, and fetal antepartum testing. Decision for Delivery vs Expectant Management 34+ Weeks Gestation: Deliver promptly upon maternal stabilization or with labor/prelabor rupture of membranes; do not delay for steroid administration. Before 34 Weeks Gestation with Severe Preeclampsia: Consider expectant management in a tertiary care setting if maternal and fetal conditions are stable. 37+ Weeks Gestation with Gestational Hypertension or Preeclampsia Without Severe Features: Opt for delivery rather than expectant management upon diagnosis. Before 37 Weeks Gestation with Gestational Hypertension or Preeclampsia Without Severe Features: Managed as an outpatient; requires frequent fetal and maternal evaluation. Deliver only if specific conditions necessitate immediate intervention. Management During Expectant Management Closely monitor maternal and fetal conditions. Serial laboratory testing: CBC, liver enzymes, serum creatinine. Use antihypertensive therapy for acute-onset severe hypertension (systolic ≥ 160 mm Hg or diastolic ≥ 110 mm Hg). Administer antenatal corticosteroids and monitor for 48 hours if delivery is indicated before 34 weeks gestation. Regularly check for Conditions Necessitating Delivery Regardless of Gestational Age Maternal Conditions Fetal Conditions HELLP syndrome Pulmonary edema Eclampsia Suspected acute placental abruption, or vaginal bleeding without placenta previa Uncontrolled severe-range blood pressure Worsening renal function Persistent headaches, epigastric/right upper quadrant pain Visual disturbances Motor deficits Altered sensorium Stroke Myocardial infarction Abnormal fetal testing Fetal death Fetus with low survival likelihood (lethal anomaly, Extreme prematurity) Persistent reversed end-diastolic flow in the umbilical artery Postpartum Management Monitor blood pressure and symptoms post-delivery. Consider NSAIDs for pain management instead of opioids. Delivery is typically done at or after 34 weeks of gestation, not necessarily at 30 weeks without severe features ( Option A ruled out) . Monitoring for fetal distress is part of ongoing management, not initial for severe preeclampsia without immediate delivery indications",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 7,
      "question": "Which of the following conditions doesn’t typically require immediate termination of pregnancy, irrespective of gestational age?",
      "options": {
        "A": "Pre-eclampsia with severe features and stable maternal and fetal conditions",
        "B": "HELLP syndrome",
        "C": "Impending eclampsia",
        "D": "PIH with abruption"
      },
      "correct_answer": "A",
      "explanation": "expectantly with close monitoring until a more optimal gestational age for delivery is reached, typically around 34 weeks gestation. Indicated delivery timing for various conditions CONDITION DELIVERY TIMING Chronic hypertension not on medications 38w0d – 39w6d Chronic hypertension controlled by medications 37w0d – 39w6d Chronic hypertension not well controlled by medications 36w0d – 37w6d Chronic Hypertension with Superimposed Preeclampsia 37weeks Gestational hypertension 37weeks Pre-eclampsia without severe features 37weeks Pre-eclampsia and Gestational Hypertension with severe features 34weeks Pre-eclampsia with severe features, unstable or prior to viability Delivery after maternal stabilization Maternal Conditions Conditions Necessitating Delivery Regardless of Gestational Age HELLP syndrome (Option B ruled out) Pulmonary edema Eclampsia & Impending Eclampsia (Option C ruled out) Suspected acute placental abruption or vaginal bleeding without placenta previa Uncontrolled severe-range blood pressure Worsening renal function Persistent headaches, epigastric/right upper quadrant pain Visual disturbances Motor deficits Altered sensorium Stroke Myocardial infarction Fetal Conditions Abnormal fetal testing Fetal death Fetus with low survival likelihood (lethal anomaly, extreme prematurity) Persistent reversed end-diastolic flow in the umbilical artery Mode of delivery recommendations: Vaginal delivery is considered appropriate when there are no typical obstetrical reasons for cesarean delivery. Cesarean delivery without a trial of labor is justified in cases where the gestational age is less than 30 weeks, and the cervix is unfavourable. Anesthesia recommendations: Regional anesthesia (Neuraxial anesthesia) is preferred for labor and delivery but, is contraindicated with coagulopathy due to potential hemorrhagic complications. Epidural anesthesia does not increase rates of cesarean delivery, pulmonary edema, or renal failure in severe preeclampsia. General anesthesia is not recommended. Reference: https://pubmed.ncbi.nlm.nih.gov/32443079/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 8,
      "question": "A 28 y/o primigravida at 32 weeks of gestation presents blood pressure of 150/95 mmHg on two separate occasions, six hours apart. She has no prior history of hypertension. Her urine protein creatinine ratio is 0.4. On P/A exam, SFH is 32 cm, FHS 140/min, uterus is relaxed and she is perceiving normal fetal movements. What is the most appropriate frequency for fetal monitoring in this patient?",
      "options": {
        "A": "Fetal heart rate (FHR) monitoring every 2 weeks",
        "B": "FHR monitoring weekly along with fetal surveillance.",
        "C": "Umbilical artery Doppler every 2 weeks",
        "D": "No fetal monitoring is necessary at this time"
      },
      "correct_answer": "B",
      "explanation": ">140/90 mmHg) after 20 weeks of gestation. Urine protein: Creatinine ratio >0.3. Fetal surveillance, including regular fetal heart rate monitoring, is essential to assess fetal well-being. The frequency depends on the severity of the pre-eclampsia. In mild pre-eclampsia, weekly monitoring is generally recommended. Mild pre-eclampsia Severe Pre-eclampsia Weekly fetal heart rate monitoring and regular prenatal checkups with a focus on: Monitoring BP. Proteinuria. Fetal well-being The Biophysical Profile (BPP) is the preferred method of fetal assessment in severe cases. Parameters to be monitored: NST Fetal movements, breathing, fetal tone Amniotic fluid volume Umbilical artery Doppler: Purpose : Assesses blood flow in the umbilical artery to monitor fetal well-being and detect placental insufficiency. Procedure : An ultrasound measures systolic and diastolic blood flow velocities in the umbilical artery. Normal Findings : Low resistance flow indicates adequate placental function and fetal health. Abnormal Findings : High resistance or absent/reversed end-diastolic flow suggests placental insufficiency and fetal distress. Clinical Utility : Essential for monitoring high-risk pregnancies, especially with conditions like pre-eclampsia and intrauterine growth restriction. Predictive Value : Helps guide clinical decisions on the timing of delivery and other interventions to improve fetal outcomes. Umbilical artery Doppler finding Delivery Timing based on finding UA reversed diastolic flow Deliver between 30 to 32 weeks UA absent diastolic flow Deliver between 33 and 34 weeks UA pulsatility index (PI) abnormal (PI >95th percentile) Deliver at 37 weeks UA PI normal (PI ≤ 95th percentile): EFW <3rd percentile and no comorbidities Deliver at 37 weeks EFW ≥ 3rd and <10th percentile and no comorbidities Deliver between 38 and 39 weeks EFW ≥ 3rd and <10th percentile with oligohydramnios or comorbidities (e.g., preeclampsia, chronic hypertension) - Timing individualized; Most should deliver between 34 and 37+6 weeks Fetal heart rate (FHR) monitoring every 2 weeks (Option A) might not be sufficient to detect early signs of fetal compromise. While umbilical artery Doppler (Option C) is a valuable tool in monitoring pregnancies complicated by pre-eclampsia, the frequency in this scenario with mild features might be excessive. Fetal monitoring (Option D) is crucial in all cases of pre-eclampsia to ensure fetal well-being.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 9,
      "question": "Which of the following is a well-established risk factor for the development of Pregnancy-Induced Hypertension (PIH), including preeclampsia and gestational hypertension?",
      "options": {
        "A": "Maternal smoking",
        "B": "Previous pregnancy with the same partner",
        "C": "Exposure to chorionic villi for the first time",
        "D": "High levels of cell-free DNA in maternal serum"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Exposure to chorionic villi for the first time Explanation: Exposure to chorionic villi for the first time is a well-established risk factor for the development of Pregnancy-Induced Hypertension (PIH), including preeclampsia and gestational hypertension. Nulliparity, meaning first pregnancy and first exposure to chorionic villi, is associated with higher risk of PIH. Immunological maladaptation to paternal antigens expressed by the chorionic villi is a key proposed mechanism. This risk decreases in subsequent pregnancies with the same partner due to immune tolerance. Maternal smoking (Option A) paradoxically reduces PIH risk. Previous pregnancy with the same partner (Option B) actually lowers risk by inducing immune tolerance. High cell-free DNA (Option D) is investigational and not established as a risk factor. Aspect Details Risk Factors for PIH Prior preeclampsia, chronic hypertension, diabetes, renal disease, autoimmune disorders Nulliparity First pregnancy; first exposure to chorionic villi increases PIH risk Multifetal gestation Increased chorionic villi quantity linked to higher risk Maternal age & Obesity Age > 35 years and obesity increase risk Family history Positive family history increases risk Smoking Paradoxically associated with lower PIH risk Biological markers Angiogenic imbalance (sFlt-1, PlGF), endothelial dysfunction are under study, not established for clinical use Cell-free DNA Investigational; no proven predictive value Reference: William’s Obstetrics, 26th Edition, Page 688, 689, 690, 691, 702, 703.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 10,
      "question": "A 38 y/o woman presents for her first prenatal visit. She is excited about the pregnancy but expresses concern about her family history of preeclampsia in her mother. The patient is otherwise healthy and has no history of hypertension. What is most likely recommended by the American College of Obstetricians and Gynecologists (ACOG) to reduce this patient's risk of developing preeclampsia?",
      "options": {
        "A": "High-dose folic acid supplementation",
        "B": "Low-dose aspirin (75-150 mg/day)",
        "C": "Prophylactic Anti-hypertensive at 20 weeks of gestation.",
        "D": "Bed rest and Observation"
      },
      "correct_answer": "B",
      "explanation": "ACOG recommends prophylactic low-dose aspirin in such patients. Method ACOG Recommendation Effectiveness Low-dose Aspirin Women at high risk for preeclampsia. Low-dose aspirin (75-150 mg/day) initiated between 12 and 28 weeks of gestation. Chronic Conditions Controlling diseases such as diabetes, hypertension, and renal disease. Pre-conception and early pregnancy management Lifestyle modifications Healthy diet, regular physical activity, weight management Emphasizes overall health Avoidance of bed rest Advises against bed rest Bed rest may cause Thromboembolic events. (Option D ruled out) High-dose folic acid supplementation (Option A) is crucial in preventing neural tube defects and not pre-eclampsia. Anti-hypertensives (Option C) are typically reserved for managing hypertension once it develops, not as a preventative measure. Reference: Williams Obstetrics, 26th Edition, Page 705.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 11,
      "question": "A 32 Y/o woman at 28 weeks of gestation presents with complaints of persistent headaches and visual disturbances. On examination, her blood pressure is 160/100 mmHg, and she has 2+ proteinuria on a urine dipstick test. Which of the following is most likely the diagnosis?",
      "options": {
        "A": "Gestational HTN",
        "B": "Chronic HTN",
        "C": "Preeclampsia",
        "D": "Eclampsia"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Preeclampsia Based on the above scenario, the patient is most likely suffering from Preeclampsia. Types of HTN in pregnancy: Gestational HTN (Option A ruled out) BP >140/90 after 20 weeks gestation at 2 separate occasions 6 hrs apart in a previously normotensive woman without proteinuria or end organ damage Chronic HTN (Option B ruled out) Pre-existing HTN presenting < 20 weeks of gestation Acute on chronic HTN Chronic HTN patient with superimposed gestational HTN New onset proteinuria after 20 weeks gestation Preeclampsia (Option C) BP >140/90 after 20 weeks gestation associated with: Proteinuria: ≥ 300 mg/24 h of urine or 1+ on urine dipstick Urine protein: Creatinine >0.3 Or End organ damage: Platelets <1,00,000/microL; Creatinine >1.1 mg/dL; doubling of serum transaminase level; headache, visual disturbances Eclampsia (Option D ruled out) Preeclampsia + generalized tonic-clonic seizures Delta HTN Sudden rise in mean arterial pressure in pregnant women, even though being at normal levels Reference: Williams Obstetrics, 26th Edition, Page 688, 689, 690.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 12,
      "question": "A 32-year-old woman in her third trimester presents to the labor and delivery unit with a blood pressure of 165/110 mm Hg, severe headache, and visual disturbances. She reports she has been experiencing swelling in her legs and face for the past week. Urinalysis reveals proteinuria. Which of the following maternal systemic effects is the MOST likely cause of this patient’s presentation?",
      "options": {
        "A": "Cerebral edema",
        "B": "Acute kidney injury",
        "C": "HELLP syndrome",
        "D": "Hypercoagulability"
      },
      "correct_answer": "A",
      "explanation": "Endothelial cell dysfunction can lead to increased capillary permeability in the brain, resulting in vasogenic edema. This swelling and pressure within the brain can cause neurological symptoms: Headache, vision problems and seizures. Systemic effects of Pregnancy-induced Hypertension (PIH): Pathophysiology Presentation Renal Reduced blood flow to the kidneys causes damage to the glomeruli. Proteinuria, renal insufficiency (increased creatinine), AKI. (Option B) Cardiovascular Increased afterload due to hypertension. Reduced preload due to diminished blood volume expansion. Endothelial activation - Fluid leakage and edema. Hypertension, decreased cardiac output, Pulmonary edema. Neurological Vasospasm leading to reduced blood flow and ischemia. Increased capillary permeability in the brain. Headaches, Visual disturbances, Seizures (eclampsia). Hematological Activation of the coagulation cascade. Endothelial damage and platelet deposition. Thrombocytopenia, Hypercoagulability (Blood clot formation) (Options D) Hepatological Reduced blood flow to the liver. Systemic inflammation and oxidative stress. Elevated liver enzymes (AST, ALT), HELLP syndrome (Elevated liver enzymes and low platelets) (Option C) Reference: Williams Obstetrics, 26th Edition, Page 699-702.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 13,
      "question": "A 28-year-old primigravida presents at 26 weeks gestation, and her pregnancy has been uncomplicated so far. Her blood pressure is measured at 150/95 mmHg on two occasions, 6 hours apart. A urine dipstick test shows proteinuria. What is the most likely mediator involved in the pathogenesis of this patient's condition?",
      "options": {
        "A": "Soluble fms-like tyrosine kinase-1 (sFlt-1)",
        "B": "Prostaglandin I2 (PGI2)",
        "C": "Nitric Oxide",
        "D": "Atrial Natriuretic Peptide (ANP)"
      },
      "correct_answer": "A",
      "explanation": "proangiogenic factors, such as vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), creating an imbalance. Factors involved in pregnancy-induced hypertension (PIH) Factors Explanation Exposure to chorionic villi First-time exposure to chorionic villi - High risk of PIH. Amount of chorionic villi Twins or a hydatidiform mole. Pre-existing maternal conditions Chronic hypertension, Renal disease, Obesity, Connective tissue disorders, Diabetes. Abnormal placental implantation Incomplete invasion of uterine vessels by trophoblasts. Maternal immune response Loss of maternal immune tolerance to placental and fetal antigens. Increased Th1 cell function causes decreased vascular modification. Angiogenic imbalance Soluble fms-like tyrosine kinase 1 (sFlt-1) and Soluble endoglin (sEng). PGI2 and Nitric oxide (Options B and C) are vasodilators produced by endothelial cells, which are unlikely to cause vasoconstriction. Although ANP levels (Option D) are elevated in preeclampsia, it is not a primary mediator of the disease. Reference: Williams Obstetrics, 26th Edition, Page 694, 695.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 14,
      "question": "A 38 y/o primigravida presents at 32 weeks gestation with a blood pressure of 165/115 mmHg and new-onset proteinuria. She has a persistent headache and blurry vision. What pathophysiologic change is most likely responsible for her clinical diagnosis?",
      "options": {
        "A": "Increased placental perfusion",
        "B": "Decreased systemic vascular resistance",
        "C": "Suppressed maternal inflammatory response",
        "D": "Inadequate spiral artery remodeling"
      },
      "correct_answer": "D",
      "explanation": "characterized by new-onset hypertension ( ≥ 140/90 mmHg) and proteinuria after 20 weeks gestation. A key underlying factor in preeclampsia is inadequate spiral artery remodelling. Feature Normal Pregnancy Pregnancy-Induced Hypertension (PIH) Placentation Extravillous trophoblasts invade the spiral arteries of the uterus around week 20. This invasion widens the spiral arteries. The widening enhances blood flow to the placenta. This is known as secondary placentation. Incomplete invasion of the spiral arteries by extravillous trophoblasts. Persistent narrow vessels with reduced blood flow and placental ischemia. Immune Response T-helper 2 cells dominate, promoting humoral immunity and tolerance of the fetal antigens. A shift towards T-helper 1 cell activity. Increasing the production of pro-inflammatory cytokines (TNF- α , γ -interferon, IL-2). Contributing to endothelial dysfunction. Endothelial Function Maintains normal vascular tone and permeability, regulating blood flow and preventing inappropriate clotting. Endothelial cells become dysfunctional, leading to vasoconstriction, increased permeability (edema), and activation of the coagulation cascade. Angiogenic Balance Pro-angiogenic factors (VEGF, PlGF, TGF- β ) promote blood vessel growth. Anti-angiogenic factors (sFlt-1, sEng) inhibit blood vessel growth. A balance between these factors is essential for proper placental development and function. Imbalance occurs with elevated production of anti-angiogenic factors (sFlt-1, sEng). Reduced levels of pro-angiogenic factors are observed. sFlt-1 binds to and deactivates VEGF and PlGF. sEng inhibits TGF- β signaling. This imbalance leads to endothelial dysfunction and impaired angiogenesis Blood Pressure Blood pressure remains within the normal range due to the vasodilatory effects of pregnancy hormones Hypertension occurs after 20 weeks of pregnancy, characterized by blood pressure over 140/90 mmHg. It results from vasoconstriction, endothelial dysfunction, and heightened sensitivity to vasopressors. Inadequate spiral artery remodelling reduces placental perfusion. ( Option A ruled out) Preeclampsia is characterized by increased systemic vascular resistance. (Option B ruled out) Preeclampsia involves a heightened maternal inflammatory response. (Option C ruled out)",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 15,
      "question": "A 32 Y/o woman at 34 weeks of gestation presents with severe upper abdominal pain, headache, and visual disturbances. She has no history of hypertension or proteinuria during this pregnancy. On examination, her blood pressure is 140/90 mmHg, and there is no significant proteinuria on a dipstick test. Laboratory tests reveal elevated liver enzymes and thrombocytopenia. Which of the following is the initial management for this patient?",
      "options": {
        "A": "Administer antihypertensive medication to control blood pressure.",
        "B": "Perform an urgent cesarean section",
        "C": "Start magnesium sulfate infusion to prevent seizures.",
        "D": "Initiate corticosteroids to promote fetal lung maturity"
      },
      "correct_answer": "C",
      "explanation": "preeclampsia. Atypical preeclampsia/eclampsia: It is defined as the development of preeclampsia/eclampsia without fulfilling the standard requirements. Examples: Early onset preeclampsia/eclampsia <20 weeks Preeclampsia/eclampsia >48 hours postpartum Treatment: Patients with atypical presentation of preeclampsia/eclampsia should be treated as severe preeclampsia. Majority of patients develop eclampsia- MgSO4 to prevent seizures (Option C) To control BP- Antihypertensives (Option A ruled out) If <34 weeks- Corticosteroids for lung maturity (Option D ruled out) Definitive treatment- termination of pregnancy (Option B ruled out)",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 16,
      "question": "A 28 Y/o pregnant woman in her second trimester at 24 weeks of gestation visits the prenatal clinic for a routine check-up. She has a history of hypertension, and her first pregnancy was complicated by preeclampsia. Which of the following is best to reduce the risk of preeclampsia in this pregnancy?",
      "options": {
        "A": "Daily supplementation with high-dose calcium.",
        "B": "Daily low-dose aspirin therapy.",
        "C": "Routine use of antihypertensive medications in the first trimester",
        "D": "Administration of low-molecular-weight heparin"
      },
      "correct_answer": "B",
      "explanation": "≥ 300 mg/24 h or end-organ damage after 20 weeks gestation. Prevention : If the patient is at high risk for preeclampsia, then starting low-dose aspirin 81 mg after 12 weeks gestation is most commonly recommended to prevent preeclampsia (Option B) . Other interventions that decrease the risk but are not as effective as aspirin are: Losing weight if obese Managing high BP and diabetes (Option C ruled out) Supplementation with calcium and antioxidants (Option A ruled out) Regular exercise and sleep schedule Low salt diet Low molecular weight heparin (Option D ruled out) Reference: Williams Obstetrics, 26th Edition, Page 704 https://my.clevelandclinic.org/health/diseases/17952-preeclampsia",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 17,
      "question": "A 32 Y/o pregnant woman at 35 weeks gestation presents to the emergency department with complaints of severe upper abdominal pain, nausea, and headaches. Blood pressure is 160/100 mmHg. Laboratory results reveal hemolysis, elevated liver enzymes, and a low platelet count. Which of the following is the definitive management for a patient's condition?",
      "options": {
        "A": "Termination of pregnancy",
        "B": "Initiation of antihypertensive therapy",
        "C": "Administration of magnesium sulfate",
        "D": "Administration of corticosteroids"
      },
      "correct_answer": "A",
      "explanation": "Correct answer: A) Termination of pregnancy Explanation: HELLP Syndrome: Rare complication of Preeclampsia, which usually occurs in the third trimester of pregnancy Features: H- Hemolysis EL- Elevated Liver enzymes LP- Low Platelets Risk factors: HELLP in prior pregnancy, age >35, multiparous, history of diabetes, kidney disease Symptoms: RUQ pain, headache, blurred vision, nausea, vomiting, edema Maternal complications: Blood clotting problems, DIC Kidney failure Liver failure Pulmonary edema Eclampsia Fetal complications: Preterm birth Growth restriction Respiratory distress Treatment: Majority of patients develop eclampsia- MgSO4 to prevent seizures (Option C) Antihypertensives to control BP (Option B) If <34 weeks, Corticosteroids for lung maturity (Option D) Definitive treatment: Termination of pregnancy (Option A) Differential diagnosis: Acute fatty liver of pregnancy. Reference: Williams Obstetrics, 26th Edition, Page 699, 714 https://my.clevelandclinic.org/health/diseases/21637-hellp-syndrome",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 18,
      "question": "A 30-year-old pregnant woman at 36 weeks of gestation presents with severe headache, visual disturbances, and epigastric pain. Her blood pressure is 170/110 mmHg, and she has +3 pitting edema in her lower extremities. Laboratory results reveal proteinuria. All of the following are signs /symptoms of impending eclampsia except?",
      "options": {
        "A": "Severe headache",
        "B": "Visual disturbances",
        "C": "Epigastric pain",
        "D": "+3 pitting edema"
      },
      "correct_answer": "D",
      "explanation": "The warning signs of imminent eclampsia include: Blood pressure ≥ 160/110 on two different occasions while the patient is on bed rest Proteinuria of <5 g/24 hours Oliguria or anuria Epigastric pain (Option C ruled out) Headache and visual symptoms (Option A and B ruled out) Pulmonary edema or cyanosis End organ damage Visual symptoms such as blurred vision, diplopia, scotomata, and amaurosis fugax are telltale signs that the patient is entering an eclamptic state from pre-eclampsia (Option B) . Treatment: Prevention of seizures with MgSO4 BP control with anti-hypertensives If <34 weeks, corticosteroids for lung maturation Termination of pregnancy is the definitive treatment Reference: https://pubmed.ncbi.nlm.nih.gov/22495060/ https://pubmed.ncbi.nlm.nih.gov/7658039/#:~:text=The%20 warning%20signs%20of%20imminent,visual%20disturbances%3B%205)%20pulmonary%20edema",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 19,
      "question": "Which of the following findings indicates Severe Preeclampsia?",
      "options": {
        "A": "Blood pressure of 150/95 mmHg",
        "B": "1+ proteinuria on urinalysis",
        "C": "Occasional swelling in the feet",
        "D": "Elevated serum creatinine"
      },
      "correct_answer": "D",
      "explanation": "ruled out) ≥ 160 mm Hg Diastolic BP <110 mm Hg ≥ 110 mm Hg Proteinuria 300 mg/24 hours or 1+ on urine dipstick (Option B ruled out) >5 gm/ 24 hours or 3+ on urine dipstick Headache and visual disturbances Absent Present Upper abdominal pain Absent Present Oliguria Absent Present Thrombocytopenia (<100000 /microL) Absent Present Serum creatinine Normal Elevated (Option D) Serum transaminases Minimally elevated Markedly elevated Fetal growth restriction Absent Present Pulmonary edema Absent Present Reference: William’s Textbook of Obstetrics, 26th Edition, pg no: 690 https://www.semanticscholar.org/paper/Chap ter-45-Hypertensive-Disorders-Polley/def338e2fde1757d2c7962edd5aeff36733b042e/figure/0",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    },
    {
      "q_no": 20,
      "question": "A 37 y/o multigravida with a history of chronic hypertension, at 28 weeks twin gestation, presents with occasional headaches and visual disturbances. Her blood pressure is measured at 150/95 mmHg, and a urine dipstick test reveals significant proteinuria. Which of the following is not a risk factor for preeclampsia for this patient?",
      "options": {
        "A": "Age",
        "B": "Multigravid",
        "C": "Twin gestation",
        "D": "Chronic hypertension"
      },
      "correct_answer": "B",
      "explanation": "≥ 300 mg/24 h or end-organ damage after 20 weeks gestation. Risk factors for preeclampsia: Nulliparity Age > 35 yrs (Option A ruled out) BMI > 30 kg/square meter Multifetal gestation (Option C ruled out) Prior abruption Diabetes mellitus Prior preeclampsia Chronic hypertension (Option D ruled out) Chronic kidney disease Molar pregnancy Systemic lupus erythematosus Antiphospholipid antibodies High risk: Prior history of preeclampsia, history of chronic hypertension, multifetal pregnancy, CKD, APLA syndrome. Multigravida is not a risk factor for Preeclampsia. (Option B) Reference: Williams Obstetrics, 26th Edition, Page 691",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Obstetrics-Hypertension In Pregnancy"
    }
  ]
}
